![](https://porib.com/wp-content/uploads/2021/07/bmc_infectious_diseases.jpg)
Sanchez-Luna M, Burgos-Pol R, Oyagüez I, Figueras-Aloy J, Sánchez-Solís M, Martinón-Torres F, Carbonell-Estrany X
Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain
BMC Infect Dis. doi: 10.1186/s12879-017-2803-0
![](https://porib.com/wp-content/uploads/2021/07/Revista-E-Enfermedades-Digestivas.jpg)
Crespo J, Esteban R, Torres C, Oyagüez I, Casado MA, Buti M